The last Cofund call closed in February 2016. The Programme will be active until 2018 for projects selected in the seven calls launched
If you are an experienced researcher, this is your opportunity to advance and disseminate your research in neglected diseases such as tuberculosis, malaria, Chagas disease, and leishmaniasis. The Tres Cantos Open Lab Foundation (TCOLF) Cofund Fellowship will give you access to GSK drug discovery expertise and industrial-scale facilities in Tres Cantos, Spain.
The Fellowship is partially funded by the European Commission through its FP7 Marie Curie co-funding program.
Why You Should Apply
There is simply no better place than Tres Cantos to explore innovative approaches to address neglected diseases. You'll be working side-by-side with Open Lab researchers and GSK scientists in a collaborative atmosphere. You'll explore innovative approaches to research, apply new skills and improve your career opportunities - all while contributing to the treatment of diseases that affect millions of people.
Qualifications to Apply
Please refer to the Guide for Applicants & FAQs for additional information on the eligibility criteria and application process.
Concept of "Home" and "Host" Institution
"Home Institutions" can be public or private Research Institutes, High Education Institutions or Companies working in the research areas supported by TCOLF. The "Host institution" is GSK's Tres Cantos Medicines Development Campus (GSK TCMDC) near Madrid, Spain. TCOLF supports collaborative projects between a "Home" and the "Host" institution. They can be implemented entirely at the GSK TCMDC, or at both the Home and the Host Institution facilities; timelines at each site must be coherent with the expertise and resources available at each site.